These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Continuous hemofiltration with a low molecular weight heparin, enoxaparine: report on two cases.
    Author: Lorenzini JL, Freysz M, Honnart D, Zeller V, Dutrillaux F.
    Journal: Int J Clin Pharmacol Ther Toxicol; 1991 Mar; 29(3):89-91. PubMed ID: 1649141.
    Abstract:
    The heparinization of multiple trauma patients during hemofiltration involves a high risk of bleeding. We report here two continuous hemofiltration cases -15 and 60 days in duration-using a low molecular weight heparin, enoxaparine. No major bleeding or clotting was observed. However, continuous infusion of the heparin is needed and the rate of delivery of the hemofiltration pump must be taken into consideration since it influences the clearance of the drug through the hemofiltration membrane. Anti-Xa activity measurement is not sufficient to adjust the heparin dose.
    [Abstract] [Full Text] [Related] [New Search]